CHM and cognitive disorder: Finally, Parkinson’s disease patients carrying the low repeat REP1 allele, which results in decreased SNCA expression (Chiba-Falek and Nussbaum, 2001), have worse motor and cognitive disease outcomes (Markopoulou et al., 2014).